Taiwan · Delayed Price · Currency is TWD PlexBio Statistics
Total Valuation
PlexBio has a market cap or net worth of TWD 797.06 million. The enterprise value is 519.10 million.
| Market Cap | 797.06M |
| Enterprise Value | 519.10M |
Important Dates
The next estimated earnings date is Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PlexBio has 103.65 million shares outstanding. The number of shares has decreased by -0.63% in one year.
| Current Share Class | 103.65M |
| Shares Outstanding | 103.65M |
| Shares Change (YoY) | -0.63% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 16.28% |
| Owned by Institutions (%) | n/a |
| Float | 39.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.79 |
| PB Ratio | 2.76 |
| P/TBV Ratio | 2.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.77 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.14, with a Debt / Equity ratio of 0.02.
| Current Ratio | 4.14 |
| Quick Ratio | 3.45 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.11 |
| Interest Coverage | -274.93 |
Financial Efficiency
Return on equity (ROE) is -12.45% and return on invested capital (ROIC) is -10.76%.
| Return on Equity (ROE) | -12.45% |
| Return on Assets (ROA) | -7.45% |
| Return on Invested Capital (ROIC) | -10.76% |
| Return on Capital Employed (ROCE) | -18.04% |
| Weighted Average Cost of Capital (WACC) | 10.13% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.30 |
| Inventory Turnover | 1.44 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.92% in the last 52 weeks. The beta is 1.08, so PlexBio's price volatility has been similar to the market average.
| Beta (5Y) | 1.08 |
| 52-Week Price Change | -19.92% |
| 50-Day Moving Average | 7.42 |
| 200-Day Moving Average | 8.28 |
| Relative Strength Index (RSI) | 55.11 |
| Average Volume (20 Days) | 112,737 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PlexBio had revenue of TWD 137.57 million and -38.38 million in losses. Loss per share was -0.37.
| Revenue | 137.57M |
| Gross Profit | 46.69M |
| Operating Income | -54.71M |
| Pretax Income | -38.38M |
| Net Income | -38.38M |
| EBITDA | -48.22M |
| EBIT | -54.71M |
| Loss Per Share | -0.37 |
Balance Sheet
The company has 283.20 million in cash and 5.23 million in debt, with a net cash position of 277.97 million or 2.68 per share.
| Cash & Cash Equivalents | 283.20M |
| Total Debt | 5.23M |
| Net Cash | 277.97M |
| Net Cash Per Share | 2.68 |
| Equity (Book Value) | 289.04M |
| Book Value Per Share | 2.82 |
| Working Capital | 283.25M |
Cash Flow
In the last 12 months, operating cash flow was -47.58 million and capital expenditures 226,000, giving a free cash flow of -47.35 million.
| Operating Cash Flow | -47.58M |
| Capital Expenditures | 226,000 |
| Depreciation & Amortization | 6.49M |
| Net Borrowing | -8.71M |
| Free Cash Flow | -47.35M |
| FCF Per Share | -0.46 |
Margins
Gross margin is 33.94%, with operating and profit margins of -39.77% and -27.90%.
| Gross Margin | 33.94% |
| Operating Margin | -39.77% |
| Pretax Margin | -27.90% |
| Profit Margin | -27.90% |
| EBITDA Margin | -35.05% |
| EBIT Margin | -39.77% |
| FCF Margin | n/a |
Dividends & Yields
PlexBio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.63% |
| Shareholder Yield | 0.63% |
| Earnings Yield | -4.81% |
| FCF Yield | -5.94% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |